The activity of Jun NH2-terminal kinase (JNK) protein is significantly elevated in various tissues in T2DM patients and animal models, which can impair insulin signaling transduction and lead to insulin resistance through activating the serine phosphorylation of insulin receptor substrate-1 (IRS-1) [4]. Here, MAPK8 is linked to type 2 diabetes mellitus.